Abstract
Session presented on Friday, July 22, 2016 and Thursday, July 21, 2016:
World-wide there is a disproportionate burden of cancer among populations of African ancestry. Cancer in the United States continues to be a major public health issue. President Obama has declared cancer to be a major priority. While cancer is a major health issue in the U.S. there is evidence of significant disparities among African Americans. Additionally, developing nations in Africa and the Caribbean continue to face this public health challenge despite current efforts and advances in health policy, research and advocacy. The World Health Organization (WHO) estimates that by 2030 the incidence of cancer in Africa and the Caribbean will increase by 87% and 66% respectively, in contrast to increases by 55% and 26% in the US and Europe. The African-Caribbean Cancer Consortium (AC3) is a designated National Cancer Institute, Epidemiology and Genomics Research (EGRP) Consortium and was conceived to address the growing burden of cancer risk in populations of African ancestry. Our initiatives have established an integrative framework designed to investigate lifestyle, genetic and environmental factors related to cancer incidence and mortality. This framework consists of three intricate networks of cancer investigators from the US, Caribbean and Africa. The AC3 membership represents 17 institutions in 12 states in the US, 13 countries in the Caribbean and 3 Countries in Africa. Since our launch in 2007, the trans-disciplinary collaborative initiatives have amassed 9 conferences and symposia, 14 presentations and 54 peer reviewed publications. Despite challenges of limited resources the AC3 member networks has established sustained and trusting relationships and regular communications that have demonstrated feasibility and promoted successful partnerships. Our priorities are to 1) continue to build knowledge, capacity and infrastructure, through training, mentorship and community engagement and 2) advance the science of cancer prevention and control in populations of African ancestry through sustained partnerships and translational research. We anticipate that these trans-disciplinary initiatives will reduce the disparate and appreciable cancer burden in populations of African ancestry.
Sigma Membership
Unknown
Type
Poster
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Global Collaborations, Cancer Research, African Ancestry
Recommended Citation
Oliver, JoAnn S. and Ragin, Camille, "United States, Africa, Caribbean collaboration: Strengths and opportunities for global cancer research" (2016). INRC (Congress). 150.
https://www.sigmarepository.org/inrc/2016/posters_2016/150
Conference Name
27th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Cape Town, South Africa
Conference Year
2016
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
United States, Africa, Caribbean collaboration: Strengths and opportunities for global cancer research
Cape Town, South Africa
Session presented on Friday, July 22, 2016 and Thursday, July 21, 2016:
World-wide there is a disproportionate burden of cancer among populations of African ancestry. Cancer in the United States continues to be a major public health issue. President Obama has declared cancer to be a major priority. While cancer is a major health issue in the U.S. there is evidence of significant disparities among African Americans. Additionally, developing nations in Africa and the Caribbean continue to face this public health challenge despite current efforts and advances in health policy, research and advocacy. The World Health Organization (WHO) estimates that by 2030 the incidence of cancer in Africa and the Caribbean will increase by 87% and 66% respectively, in contrast to increases by 55% and 26% in the US and Europe. The African-Caribbean Cancer Consortium (AC3) is a designated National Cancer Institute, Epidemiology and Genomics Research (EGRP) Consortium and was conceived to address the growing burden of cancer risk in populations of African ancestry. Our initiatives have established an integrative framework designed to investigate lifestyle, genetic and environmental factors related to cancer incidence and mortality. This framework consists of three intricate networks of cancer investigators from the US, Caribbean and Africa. The AC3 membership represents 17 institutions in 12 states in the US, 13 countries in the Caribbean and 3 Countries in Africa. Since our launch in 2007, the trans-disciplinary collaborative initiatives have amassed 9 conferences and symposia, 14 presentations and 54 peer reviewed publications. Despite challenges of limited resources the AC3 member networks has established sustained and trusting relationships and regular communications that have demonstrated feasibility and promoted successful partnerships. Our priorities are to 1) continue to build knowledge, capacity and infrastructure, through training, mentorship and community engagement and 2) advance the science of cancer prevention and control in populations of African ancestry through sustained partnerships and translational research. We anticipate that these trans-disciplinary initiatives will reduce the disparate and appreciable cancer burden in populations of African ancestry.